Alpha 2.0
Login Register
» Journals » Horm Res

Hormone Research

Hormone Research is a scientific journal, published since 1973 in English. The journal's country of origin is Switzerland and its primary focus area is endocrinology.
Details
Abbr. Horm Res
Start 1973
End 2009
Frequency Twelve no. a year
p-ISSN 0301-0163
e-ISSN 1423-0046
Country Switzerland
Language English
Specialty Endocrinology
Recent Articles
1.
Abstracts of the LWPES/ESPE 8th Joint Meeting Global Care in Paediatric Endocrinology, in collaboration with APEG, APPES, JSPE and SLEP. New York City, New York, USA. September 9-12, 2009
Horm Res . 2011 Oct; 72 Suppl 3:1-547. PMID: 22001871
No abstract available.
2.
Abstracts of the 47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Istanbul, Turkey. September 20-23, 2008
Horm Res . 2011 Oct; 70 Suppl 1:1-281. PMID: 22001854
No abstract available.
3.
Abstracts of the 46th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Helsinki, Finland. June 27-30, 2007
Horm Res . 2011 Oct; 68 Suppl 1:1-282. PMID: 22001793
No abstract available.
4.
Genetic and pathogenetic aspects of Noonan syndrome and related disorders
Zenker M
Horm Res . 2009 Dec; 72 Suppl 2:57-63. PMID: 20029240
Noonan syndrome (NS) and the clinically overlapping disorders cardio-facio-cutaneous syndrome, LEOPARD syndrome, Costello syndrome and Neurofibromatosis-Noonan syndrome share the clinical features of short stature, the same spectrum of congenital heart...
5.
Response to growth hormone in short children with Noonan syndrome: correlation to genotype
Binder G
Horm Res . 2009 Dec; 72 Suppl 2:52-6. PMID: 20029239
Short stature is a major characteristic of Noonan syndrome (NS), the biological basis of which is not yet clear. In around half of all individuals with NS, the cytoplasmic tyrosine...
6.
Growth hormone and the heart in Noonan syndrome
Noordam C
Horm Res . 2009 Dec; 72 Suppl 2:49-51. PMID: 20029238
Background: The clinical hallmarks of Noonan syndrome (NS) are facial dysmorphism, short stature and cardiac defects. As one of the common cardiac defects in NS is hypertrophic cardiomyopathy, there have...
7.
GH therapy in Noonan syndrome: Review of final height data
Dahlgren J
Horm Res . 2009 Dec; 72 Suppl 2:46-8. PMID: 20029237
Background And Aims: Several studies, despite using small cohorts, have shown a short-term improvement in the height velocity of short children with Noonan syndrome (NS) when treated with recombinant growth...
8.
Growth hormone therapy in Noonan syndrome: growth response and characteristics
Westphal O
Horm Res . 2009 Dec; 72 Suppl 2:41-5. PMID: 20029236
Growth hormone treatment in Noonan syndrome increases growth velocity significantly during the first 2 years of treatment and, to some extent, until puberty. This increase is more pronounced if treatment...
9.
Noonan syndrome: growth to growth hormone - the experience of observational studies
Ranke M
Horm Res . 2009 Dec; 72 Suppl 2:36-40. PMID: 20029235
Short stature is one of the key features of Noonan syndrome (NS). Attempts have therefore been made to improve height by means of recombinant human growth hormone (rhGH) treatment. Most...
10.
Growth in Noonan syndrome
Otten B, Noordam C
Horm Res . 2009 Dec; 72 Suppl 2:31-5. PMID: 20029234
Growth failure in Noonan syndrome is mainly postnatal of character and is dominated by slow maturation and late puberty. The postnatal early decline seems to be an intrinsic part of...